<PAGE>
EXHIBIT 23.1
INDEPENDENT AUDITORS' CONSENT
The Board of Directors
Nexell Therapeutics Inc.:
We consent to the use of our report dated February 4, 2000, incorporated
by reference in the post-effective amendment to the registration statement on
Form S-3 of Nexell Therapeutics Inc., relating to the consolidated balance
sheets of Nexell Therapeutics Inc. and subsidiaries as of December 31, 1999 and
1998, and the related consolidated statements of operations, changes in
shareholder's equity and cash flows for each of the years in the three-year
period ended December 31, 1999, and to the reference to our firm under the
heading "Experts" in the prospectus.
/S/ KPMG LLP
Orange County, California
January 9, 2001
